AI Robotics in Medicine

Medtronic introduced Touch Surgery Aide, a real-time OR AI platform built on NVIDIA’s Holoscan/CUDA/TensorRT, and secured FDA clearance for its first app, Instrument Exit Point, on the Hugo robotic system.

Touting simultaneous multi-app capability and a path from robotics into laparoscopy, it extends an ecosystem already in 1,500 ORs and will debut at the Society of Robotic Surgery meeting July 23–26.

Watch the expansion tempo: Hugo has a December 2025 urologic clearance and Medtronic filed June 2026 510(k)s to extend U.S. use to general and gynecologic procedures—signaling stepwise growth from a narrowly scoped first use case.

Tracking: Medicine Robotics · AI Medicine · AI Healthcare

Geography: United States, European Union, United Kingdom, Canada, Israel, China, Japan, South Korea, Singapore, India, Switzerland, Boston, San Francisco Bay Area, London, Cambridge (UK), Tel Aviv, Seoul, Tokyo, Toronto

1. Medtronic unveils real-time OR AI platform; FDA clears first app

Medtronic unveiled Touch Surgery Aide, an AI-native computing platform for the operating room that enables real-time decision support during procedures.

Built on NVIDIA’s Holoscan, CUDA, and TensorRT, the system will be showcased at the Society of Robotic Surgery meeting in Florida on July 23–26.

It extends the Touch Surgery ecosystem—already in more than 1,500 operating rooms—by processing surgical video and context in real time and running multiple AI applications simultaneously.

The first application on the platform, Instrument Exit Point (IEP), received FDA clearance for use with Medtronic’s Hugo robotic-assisted surgery system.

IEP provides a visual alert when select instruments move beyond the visible field during a robotic procedure, and the platform is designed to expand into laparoscopic surgery over time.

Medtronic also noted Hugo’s December 2025 FDA clearance for urologic procedures and June 2026 510(k) submissions to extend U.S. use to general and gynecologic specialties.

Key facts:

- July 21, 2026: Medtronic unveiled Touch Surgery Aide for real-time AI in the OR.

- Platform uses NVIDIA Holoscan, CUDA, and TensorRT for accelerated intraoperative inference.

- Debut set for SRS 2026 in Florida, July 23–26.

- Touch Surgery ecosystem runs in more than 1,500 operating rooms worldwide.

- First app, Instrument Exit Point, received FDA clearance for robotic procedures.

Why it matters: Real-time, in-procedure AI moves surgical support from retrospective review to active safety and workflow assistance. A simple, safety-relevant alert for instrument blind spots is a credible entry point to build clinician trust in intraoperative AI.

Anchoring the stack on NVIDIA’s OR-grade compute and pairing it with an FDA-cleared app positions Touch Surgery as a scalable platform rather than a point feature.

Hospitals already on Touch Surgery gain a clearer upgrade path, while Hugo’s pending U.S. indications could widen access points for deployment.

Watch for additional cleared apps, laparoscopic support, and hospital policies for data governance as the platform is designed to “learn and evolve. ”

News